Your browser doesn't support javascript.
loading
Efficacy and Safety of Nebulized Glycopyrrolate/eFlow® Closed System in Patients with Moderate-to-Very-Severe Chronic Obstructive Pulmonary Disease with Pre-Existing Cardiovascular Risk Factors.
Ferguson, Gary T; Tosiello, Robert; Sanjar, Shahin; Goodin, Thomas.
Affiliation
  • Ferguson GT; Pulmonary Research Institute of Southeast Michigan, Farmington Hills.
  • Tosiello R; Sunovion Pharmaceuticals Inc., Marlborough, Massachusetts.
  • Sanjar S; Sunovion Pharmaceuticals Inc., Marlborough, Massachusetts.
  • Goodin T; Sunovion Pharmaceuticals Inc., Marlborough, Massachusetts.
Chronic Obstr Pulm Dis ; 6(1): 86-99, 2018 Dec 13.
Article in En | MEDLINE | ID: mdl-30775427
Key words
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Type of study: Clinical_trials / Etiology_studies / Risk_factors_studies Aspects: Patient_preference Language: En Journal: Chronic Obstr Pulm Dis Year: 2018 Document type: Article Country of publication: Estados Unidos
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Type of study: Clinical_trials / Etiology_studies / Risk_factors_studies Aspects: Patient_preference Language: En Journal: Chronic Obstr Pulm Dis Year: 2018 Document type: Article Country of publication: Estados Unidos